Lacto-Freedom Probiotic for People Who Are Sensitive to Lactose
Ken Manzo, the founder of Manzo Pharmaceuticals, LLC., (OTC:MNZO) is pleased to announce the launch of a new and unique patented probiotic, "Lacto-Freedom Probiotic". It stays in the intestines and aids in the digestion of lactose containing foods, designed specifically for people who do not properly digest lactose in dairy products. Lacto-Freedom™ probiotic prevents abdominal pain, gas, abdominal bloating, diarrhea, and nausea that may result from lactose sensitivity. It is taken for only 7 days and the lactose digesting effects last for months.Manzo Pharmaceuticals, Inc. Announced Today That the Company's President, Kenneth Manzo, Has Received a Verbal Wells Notice from the US Securities and Exchange Commission
Manzo Pharmaceuticals, Inc. (OTCPink:MNZO) announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.Manzo Pharmaceuticals Receives Top Customer Ratings for Their Safe and Non-Habit Forming Natural Sleep Aid
Providing a natural and non habit forming solution for people to aid their sleep, Manzo Pharmaceuticals' SOMNAID is getting consistent five star reviews from customers. Manufactured in USA under strict GMP quality control guidelines, these pills have no side effects.Kenneth Manzo, CEO Manzo Pharmaceuticals, Visited the Probiotic Manufacturing Plant and Was Impressed with the Manufacturer, and Production Has Commenced
CEO of Manzo Pharmaceuticals (OTCPink:MNZO) and creator of patented Lacto-Freedom probiotic, Kenneth Manzo, recently visited their manufacturer's GMP and FDA approved probiotic plant in the USA and expressed his great satisfaction with the manufacturer and their professionalism.